male patient fits the expected demographic pattern of patients with glioblastomas, the 42-year-old female patient does not quite as well. For this and other reasons, the authors' observation should not be easily dismissed as anecdotical. So far, a number of adverse effects have been associated with CI but not the induction of brain tumors. Therefore, it is likely that a possible connection between CI and the induction of brain tumors has been underreported so far because no one ever thought about the possibility of a causal relationship. Another point that deserves attention is the latency period from the implant of the CI to the diagnosis of GBM in these two patients, which was 7 and more than 23 years, respectively. This latency period is suggestive of a causal relationship just like the GBMs' occurrence in close proximity to the CI transmitting devices on the skull bone. Furthermore, we know that the external application of alternating electrical fields (AEFs) to the skull i n t e r f e r e s w i t h t h e a b i l i t y o f d e e p -s e a t e d intraparenchymal tumor cells to replicate [4] . Obviously, this kind of treatment has an effect at the subcellular level, influencing the cells' mitotic processes. The question arises whether the application of continuous, long-term, external electrical fields to the brain as seen in CI may have a detrimental effect on the brain parenchyma, placing patients at higher risk for brain tumor induction.
In conclusion, because of the demographics, tumor location, latency period, and long-term application of electrical fields to the brain, as reported in these two patients with CI, the authors may have found a problem deserving our attention. A heightened vigilance of the neurosurgical community may be indicated since neurosurgeons are the most likely specialists to see patients with CI and brain tumors.
